Nephron Downgrades Avantor Inc. (AVTR) to Sell
Tweet
Share
E-mailGet Alerts AVTR Hot Sheet
Price: $15.12 +0.13%
Rating Summary:
6 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 37
Rating Summary:
6 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 7 | New: 37
Join SI Premium – FREE
Nephron downgraded Avantor Inc. (NYSE: AVTR) from Hold to Sell.
For an analyst ratings summary and ratings history on Avantor Inc. click here. For more ratings news on Avantor Inc. click here.
Shares of Avantor Inc. closed at $11.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Downgrades Heartbeam Inc. (BEAT) to Neutral
- Goldman Sachs on Viking Therapeutic (VKTX): 'we believe these results look encouraging'
- Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
